June 23, 2016
High drug prices have led to a proliferation of value models that investigate how the United States can control ballooning health care costs. But just how realistic are these models – and their implementation?
June 21, 2016
Stakeholders are divided over a provision of the Food and Drug Administration’s draft regulatory guidance on biosimilar labeling, letters to the FDA reveal.
June 17, 2016
Co-pays are high and health care is far from optimal for Americans with chronic obstructive pulmonary disease (COPD), says a new report from The Lancet Respiratory Medicine Commission.
June 15, 2016
As more biosimilars become available globally, clinicians are eager to understand: How does switching between biological medicines affect patients?
June 9, 2016
Health care in 2017 is shaping up to be expensive. Citing financial losses, private insurers who offer health plans through an Affordable Care Act exchange want to increase their premiums – some by double digits.
June 7, 2016
Vice President Joe Biden addressed oncologists, industry and medical professionals in Chicago Monday with a resounding plea: collaborate to “translate scientific discovery into meaningful treatments.”
June 2, 2016
Pain advocates on this side of the Atlantic could learn from our European counterparts when considering how to advance balanced pain management.
May 31, 2016
As federal and state governments move to curb opioid abuse, the American Society of Clinical Oncology (ASCO) wants leaders to remember: Cancer patients still need access to pain management medications.
May 26, 2016
A movement to make cancer treatment more personalized, more targeted and more effective has real potential for patients – but only if they can access the needed diagnostics and medications.
May 24, 2016
Three months after President Barack Obama requested congressional funding to fight the Zika virus, the House of Representatives has authorized $622 million in aid. But will congressional funding be too little, too late for those fighting Zika?
